期刊文献+

超顺磁性氧化铁在大鼠诱癌模型磁共振诊断与鉴别诊断中的作用 被引量:3

Evaluation of SPIO-enhanced MRI in the Diagnosis and Differentiation of Chemically-induced HCC in Rats
下载PDF
导出
摘要 目的 研究超顺磁性氧化铁 (SPIO)在大鼠诱癌模型的磁共振成像中对增生性结节与肝癌的鉴别作用 ,以及SPIO增强前后对各型肝癌的检出率。材料与方法  4 2只诱发型肝癌模型鼠在肝硬化多发增生性结节基础上 ,共计生成 379个肝癌 ,行平扫及SPIO增强扫描 ,分析增生性结节与肝癌的不同强化方式 ,并与病理对照统计平扫与增强扫描各型肝癌的检出率。结果 增生性结节在SPIO增强扫描T2 WI上信号明显降低 ,而肝癌的信号无明显改变 ;肝癌SPIO增强扫描T2 WI检出率与病理接近 ,而平扫T2 WI检出率与病理相差显著 ,其中平扫微癌与小癌的漏检率分别达 32 .9%与 1 2 .9%。结论 SPIO是一种有效的检测肝癌的磁共振对比剂 。 Objective To evaluate the potentiality of superparamagnetic iron oxide (SPIO) enhanced MR imaging in differentiating hepatocellular carcinomas (HCC) from hyperplastic nodules which were chemically induced in experimental rats, and to compare the detecting rate before and after SPIO enhancement for HCC of different type.Materials and Methods Forty two rats with 379 chemically induced liver tumors underwent T 1 and T 2 weighted MR imaging before and after the injection of SPIO. The enhanced patterns of the tumors and hyperplastic nodules were observed and analyzed. The detecting rate of each type of HCC was compared between MRI and pathological results.Results The signal of HCC was unchanged after enhancement on T 2WI, while the signal of hyperplastic nodule was markedly decreased. Significant difference in detecting rate of HCC existed between plain T 2WI and pathologic results, although no significant difference was found between SPIO enhanced T 2WI and pathology. The missed diagnosis rate of small HCC and micro HCC for plain T 2WI was 32.9% and 12.9%, respectively. Conclusion SPIO is an effective MR contrast agent for detecting HCC. The use of it can increase the detecting rate of small HCC and is helpful for the differentiation of HCC with hyperplastic nodule.
出处 《临床放射学杂志》 CSCD 北大核心 2003年第6期512-516,共5页 Journal of Clinical Radiology
基金 国家自然基金资助课题(批准号:39970728)
关键词 肝肿瘤 肝癌 超顺磁性氧化铁 大鼠 磁共振成像 SPIO增强 Neoplasm, hepatic MRI Contrast media
  • 相关文献

参考文献12

  • 1陶文照 何德华 戴益民 等.黄曲霉毒索B1诱发大鼠肝癌的癌前病变与肝癌的组织发生学[J].第二军医大学学报,1988,9:112-112.
  • 2Saini S, Stark DD, Hahn PF,et al. Ferrite particles: A superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology,1987, 162:211.
  • 3Saini S, Stark DD, Hahn PF,et al. Ferrite particles: A superparamagnetic MR contrast agent for enhanced detection of liver carcinoma. Radiology, 1987, 162:217.
  • 4Kawamori Y, Matsui O, Kadoya M,et al. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging. Radiology, 1992, 183:65.
  • 5Ishida T, Murakami T, Kato N,et al. Superparamagnetic iron oxide enhanced magnetic resonance imaging of rat liver with hepatocellular carcinoma and benign hyperplastic nodule. Investigative Radiology, 1997,32:282.
  • 6Choi Lee Han. Detection of hypervascular nodular hepatocellular carcinomas: Value of triphasic helical CT comparvd with lodized-oil CT.AJR, 1997, 168:219.
  • 7Runge VM, Rijcken THP, Davidoff A, et al. Contrast-enhanced MR imaging of the liver.JMRI, 1994, 4:281.
  • 8Nakanuma Y, Terada T, Terasaki S,et al. "Atypical adenomatous hyperplasia" in liver cirrhosis: Low-grade hepatocellular carcinoma or borderline lesion? Histopathology, 1990, 17:27.
  • 9Ros PR, Freeny PC, Harms SE,et al. Hepatic MR imaging with ferumoxides: A multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology, 1995, 196:481.
  • 10Yamamoto H, Yamashita Y, Yoshimatsu S,et al. Hepatocellular carcinoma in cirrhotic livers: Detection with unenhanced and iron oxide-enhanced MR imaging. Radiology, 1995, 195:106.

二级参考文献6

共引文献70

同被引文献39

  • 1洪霞,郭薇,李军,刘艳梅,杨文胜,白玉白,李铁津,袁航,马岚.Fe_3O_4/葡聚糖/抗体磁性纳米生物探针的制备和层析检测[J].高等学校化学学报,2004,25(3):445-447. 被引量:31
  • 2赵卫东,管生,李卉,奥红,陈中伟,彭卫军,毛健.二乙基亚硝胺诱导大鼠肝细胞癌系列病理改变及其磁共振成像[J].山西医药杂志,2005,34(3):182-185. 被引量:2
  • 3Mattoussi H, Mauro JM, Goldman ER, et al. Self-assemebly of CdSe ZnS quantum dot bioconjugates using an engineered recombinant protein [J]. J Am Chem Soci ,2000,122(49) : 12142-12150.
  • 4Pathak S, Choi SK, Amhaeim N, et al. Hydroxylated quantum dots as luminescent probes for in situ hybridization[J]. J Am Chem Soci,2001,123(17):4103-4104.
  • 5Ixtbbe AS,Bergemann C,Huhnt W,et al. Ptechnical experience with magnetic drug targeting :Tolerance and efficiency[J]. Cancer Res,1996,56:4694-4701.
  • 6Lacava L,Garcia V,Kuckelhaus S,et al. Long-term retention of dextran-coated magnetite nanoparticles in the liver and spleen [J]. J Mag:netism and Magnetic Mater, 2004, (272-276): 2434-2435.
  • 7Savic R,Luo L,Eisenberg A,et al. Micellar nanocontainers ditribute to define cytoplasmic organelles[J]. Science,2003,300(5619):615-618.
  • 8Abrol S, Trehan A, Katare OP. Formulation, characterization, and in vitro evaluation of silymarin-loaded lipid microspheres [J]. Drug Deliver,2004 , 11(3): 185-191.
  • 9Matsuoka F,Shinkai M,Honda H,et al. Hyperthermia using magnetite cationic liposomes for hamster osteosarcoma[J]. Biomagn Res Technol. 2004.2:1-6.
  • 10Stark D. Superparamagnetic iron oxide: Clinical application as a contrast agent for MRI imaging of the liver[J]. Radiology, 1988,168(2): 297-301.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部